A234080 Share Price Performance
₩12,070.00
420.00 (3.61%)
Price ₩12,070.00
Share Price₩12,070.00
A234080 Community Narratives
There are no narratives available yet.
Recent A234080 News & Updates
No updates
JW Lifescience Corporation Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 2.90k
- Gross Margin
- 25.19%
- Net Profit Margin
- 18.48%
- Debt/Equity Ratio
- 32.1%
JW Lifescience Corporation Competitors
About A234080
- Founded
- 1994
- Employees
- 301
- CEO
- WebsiteView website
JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea.
South Korean Market Performance
- 7 Days: -0.5%
- 3 Months: 23.2%
- 1 Year: 22.9%
- Year to Date: 31.8%
The Utilities sector gained 6.3% while the market remained flat over the last week. As for the longer term, the market has risen 23% in the past 12 months. As for the next few years, earnings are expected to grow by 22% per annum. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading